BTE Technologies, LLC

BTE Technologies, LLC, a for-profit manufacturer of rehabilitation and medical evaluation devices headquartered in Hanover, Maryland, operates as a prime contractor (100% of recent awards) on the GSA Federal Supply Schedule for Medical Equipment and Supplies (FSS-65-II-A), supplying specialized sensory integration, occupational therapy, and neuromuscular analysis equipment to the Department of Veterans Affairs, Department of Defense, and Department of the Army Medical Command. BTE is a subsidiary of Emerson Electric Co.'s White-Rodgers Division and competes in full-and-open procurement without SBA set-aside designations, though select awards carry Total Small Business set-aside marks.

BTE's capability portfolio centers on three product lines: PRIMUS RS and PRIMUS OS functional rehabilitation and objective evaluation systems; EVALTECH sensory integration and neuromuscular analysis devices; and SIM II occupational therapy equipment. Recent representative awards include a $71,496 delivery order from the Department of Veterans Affairs Veterans Integrated Service Network 7 (July 2026) for a PRIMUS OS Chair, a $54,181 delivery order from VISN 22 (May 2026) for a full-suite testing system, and a $60,513 delivery order from the Defense Health Agency (September 2025) for an EVALTECH 900MHz 120V device — all under FSS-65-II-A. Earlier work includes a $74,467 delivery order from the Defense Health Agency (May 2023) for a PRIMUS RS occupational therapy system and a $67,307 purchase order from the Army Medical Command (August 2022) for a PRIMUS RS neuromuscular analyzer.

Customer concentration is pronounced within federal healthcare. The top customer by award count, the Department of the Army Medical Command, placed 58 awards (about 19% of the 300-award portfolio) for $2.5 million combined potential value. The Department of Veterans Affairs across VISN divisions and headquarters accounted for 26 awards. However, the top customer by dollars is VA VISN 12, which anchors 5 awards carrying $9 million — about 48% of the vendor's combined potential value of $18.8 million. The Department of the Navy Bureau of Medicine and Surgery placed 36 awards (36 awards, $832 thousand). These three customers dominate the portfolio; the top five by potential value account for 70% of combined potential value. BTE operates predominantly under the Medical Equipment and Supplies GSA Schedule (62 task orders, $3.2 million combined potential value), supplemented by Federal Supply Schedules V797P4031A (91 task orders, $3.2 million) and V797P3325J (37 task orders).

Activity has declined sharply: four awards in 2022, declining to two in 2026 year-to-date. Only four awards (combined potential value $152 thousand) complete in the next twenty-four months, reflecting a low near-term recompete exposure for BTE but also signaling reduced pipeline momentum. BTE has maintained consistent federal contractor status since 2002, with $11.4 million obligated across its portfolio (61% of combined potential value), and operates exclusively as a prime — no subcontractor relationships appear in the source. The vendor's NAICS footprint is tightly specialized: Electromedical and Electrotherapeutic Apparatus Manufacturing (118 awards) and Surgical and Medical Instrument Manufacturing (97 awards) comprise most of its classification profile, with Medical and Surgical Instruments and Hospital Equipment (166 awards) dominating the PSC coding.